Prior Authorization
HEALTH POLICY BRIEF — Friday, October 16
Today’s pressure point is operational evidence: CMS is asking states to maintain the daily data that keeps dual-eligible coverage aligned, while its Star…
Federal health IT policy: interoperability, AI governance, prior authorization, privacy and cybersecurity. Health Policy Signal is a personal publication, independent of any employer. About Matt Reid · Disclosures
Prior Authorization
Today’s pressure point is operational evidence: CMS is asking states to maintain the daily data that keeps dual-eligible coverage aligned, while its Star…
Interoperability
CMS is putting precise numbers behind Marketplace cleanup—189,000 records and a projected $1.5 billion in savings—but not the error and reinstatement…
AI Governance
The National Institutes of Health wants to give artificial intelligence a more explicit home in its organizational chart.
Interoperability
CMS is moving its rural-health program from award ceremony to implementation, and that shift exposes the real policy test: whether new equipment…
AI Governance
The useful signal this morning comes from the states, not Washington: Utah is turning independent clinical evaluation into a condition of health-AI…
Privacy and Security
Today’s pressure point is operational accountability.
Physician Payment
CMS has turned the end of the week into an operations drill: a bad email address can shut off Medicare eligibility transactions, small practices face a…
Administrative Simplification
CMS is asking for comments by October 9 on five Medicaid and CHIP information collections packaged under its expedited “generic” clearance process.
Privacy and Security
CMS has opened a consequential but technical front: modernizing remote laboratory work without letting accountability evaporate into the cloud.
Interoperability
Washington’s live pressure point is data that can actually be used.
Administrative Simplification
CMS is proposing a small but concrete paperwork change for applicants seeking transitional pass-through payment for new drugs, biologicals, and…
Briefing
The price-transparency fight is moving from “publish the data” to “make the data usable—and prove it is honest.”